There are only few evidences that CD300A was found to be significantly overexpressed in hematological malignancies, such as acute lymphoblastic leukemia (ALL),26, 27 AML,28 and diffuse large B‐cell lymphoma (DLBCL).29 The gene discussed is CD300A; the disease is diffuse large B-cell lymphoma.